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Abstract
During canonical Wnt signalling, the activity of nuclear b-catenin
is largely mediated by the TCF/LEF family of transcription factors.
To challenge this view, we used the CRISPR/Cas9 genome editing
approach to generate HEK 293T cell clones lacking all four TCF/LEF
genes. By performing unbiased whole transcriptome sequencing
analysis, we found that a subset of b-catenin transcriptional
targets did not require TCF/LEF factors for their regulation. Consis-
tent with this finding, we observed in a genome-wide analysis that
b-catenin occupied specific genomic regions in the absence of TCF/
LEF. Finally, we revealed the existence of a transcriptional activity
of b-catenin that specifically appears when TCF/LEF factors are
absent, and refer to this as b-catenin-GHOST response. Collec-
tively, this study uncovers a previously neglected modus operandi
of b-catenin that bypasses the TCF/LEF transcription factors.
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Introduction
Wnt signalling refers to a set of evolutionarily conserved signalling
pathways which play important roles in initiating and regulating a
diverse range of cellular activities, including cell proliferation, cell
polarity, movement, differentiation, survival, self-renewal and
calcium homeostasis (Logan & Nusse, 2004; Clevers, 2006; Städeli
et al, 2006; Raymond Habas, 2008; Chien et al, 2009; Grumolato
et al, 2010; Mohammed et al, 2016). The importance of so-called
canonical Wnt signalling goes beyond embryonic development, as
its constitutive activation has been implicated in the pathogenesis of
several different cancers and hereditary diseases (Laudes, 2011;
Clevers & Nusse, 2012; Polakis, 2012; Kahn, 2014).
The current model of canonical, b-catenin-mediated Wnt signal-
ling is that in the absence of Wnt ligands, free cytoplasmic b-catenin
is rapidly sequestered by a cytoplasmic “destruction complex” that
consists of Axin, the adenomatous polyposis coli (APC) tumour
suppressor protein, glycogen synthase kinase 3 (GSK3a and GSK3b,
both referred to as GSK3) and casein kinase 1 (CK1). b-Catenin is
subsequently marked for degradation by GSK3-dependent phospho-
rylation at key amino-terminal Ser and Thr residues (Mosimann
et al, 2009; King et al, 2012). Wnt ligands inhibit the b-catenin
“destruction complex”, resulting in the accumulation of free cyto-
plasmic b-catenin, and its nuclear import (MacDonald et al, 2009;
MacDonald & He, 2012). Within the nucleus, b-catenin specifically
binds to proteins of the TCF/LEF (T-cell factor/lymphoid enhancer
factor) family of transcription factors, in order to activate the tran-
scription of Wnt target genes (van Amerongen, 2012; Niehrs, 2012).
Vertebrate genomes encode four TCF protein family members:
three of them act preferentially as activators, TCF7, LEF1, and
TCF7L2, and one as repressor, TCF7L1 (Hoppler & Kavanagh,
2007). The activation of target genes by the b-catenin/TCF complex
has been established as the main modus operandi of canonical Wnt
signalling (Cadigan & Waterman, 2012; Nusse & Clevers, 2017), and
recent studies both in mammals (Schuijers et al, 2014) and in Droso-
phila (Franz et al, 2017) provide additional evidence that Wnt-
dependent transcriptional output is predominantly executed by the
partnership between TCF and b-catenin.
However, several studies have also suggested the existence of alter-
native interactors of b-catenin in various cell types. These include
members of the SOX family (Kormish et al, 2009), FOXO proteins
(Essers, 2005), the homeodomain protein PITX2 (Vadlamudi, 2005),
hypoxia-inducible factor Ιa (HIFIa) (Kaidi et al, 2007) and the bHLH
protein MyoD (Kim et al, 2008). These findings, while awaiting inde-
pendent confirmation, suggest the existence of one or more alternative
branches within the canonical Wnt/b-catenin signalling pathway that
are capable of bypassing TCF/LEF transcription factors. A difficulty in
identifying TCF-independent functions of b-catenin could possibly
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arise due to the genetic redundancy of the four TCF/LEF encoding
genes (Cadigan & Waterman, 2012), an aspect that rendered a genetic
approach to this question practically inaccessible. Therefore, the
discovery of TCF/LEF-independent branches might so far have been
elusive due to the inability to simultaneously mutate or remove all
TCF/LEF paralogous genes in a single cellular system, a technical
challenge that, however, the advent of the CRISPR/Cas9 technique in
human cells allowed us to overcome (Hsu et al, 2014; Sander & Joung,
2014; Moreira et al, 2017).
Here, we genetically engineered human HEK 293T cell clones that
lack all four genes encoding TCF/LEF proteins or, alternatively, b-
catenin. We used these tools to specifically test the existence of a b-
catenin-mediated transcriptional activity that is independent of TCF/
LEF factors. We present evidence for the existence of this phenom-
enon on two levels: (i) transcriptomics studies unveil genes whose
expression rely on the presence of b-catenin but not of TCF/LEF
factors, and (ii) despite its genome-wide DNA-binding profile being
largely perturbed, b-catenin still exhibits physical association with
chromosomes in the absence of TCF/LEF proteins. Intriguingly, our
data reveal that, when TCF/LEF proteins are lacking, b-catenin
embarks on the regulation of a different set of genes and binds alter-
native genomic locations. We refer to this phenomenon as the b-
catenin-GHOST response. The transcriptional regulation of b-catenin-
GHOST targets only occurs when TCF/LEF factors are absent, or
when the b-catenin/TCF interaction is inhibited. We speculate that
the b-catenin-GHOST response is mediated by crosstalk with other
transcription factors, such as FOXO proteins.
Results
CRISPR/Cas9-mediated generation of TCF/LEF and b-catenin
null cells
The TCF/LEF transcription factors are considered to act as main
intermediaries of so-called canonical, b-catenin-mediated Wnt
signalling (Clevers & Nusse, 2012). Recent high-throughput studies
confirmed this tenet in Drosophila (Franz et al, 2017) and in
mammalian cells (Schuijers et al, 2014). However, a few studies
reported the ability of b-catenin to control gene transcription via
interaction with non-TCF transcription factors. For example, b-
catenin interacts with FOXO transcription factors, YAP1 and TBX5
in human cancer cells (Essers, 2005; Hoogeboom et al, 2008;
Rosenbluh et al, 2012), and forms a complex with Oct4 to promote
Oct4-driven pluripotency in embryonic stem cells (Kelly et al,
2011). Moreover, b-catenin cooperates in Xenopus with Sox17 in the
activation of Sox17 target genes (Sinner, 2004). In addition, recent
chromatin immunoprecipitation (ChIP) studies uncovered the possi-
bility of genomic regions occupied by b-catenin but not by TCF7,
TCF7L1, TCF7L2 or LEF1, indicating that recruitment of b-catenin
via these transcription factors cannot account for the full extent of
its genomic occupancy (Schuijers et al, 2014).
We reasoned that generating loss-of-function mutations of all four
TCF/LEF genes in the same cellular system would constitute a
powerful tool to conclusively test this. Taking advantage of CRISPR/
Cas9 technology, we aimed at generating cell lines lacking all four
TCF/LEF genes (Fig 1A). We chose human HEK 293T cells, an excel-
lent model platform to study gene regulation downstream of
b-catenin and TCF/LEF, for they are (i) widely used to study the
biochemical events underlying the Wnt signalling pathway, (ii) do
not carry pathway-specific activating mutations (Gujral & MacBeath,
2010) and (iii) are highly responsive to Wnt pathway activation, in
that b-catenin only translocates into the nucleus when GSK3 is
inhibited (Li et al, 2012). We confirmed that all TCF/LEF genes are
expressed in our HEK 293T parental cells (Fig 1B). TCF/LEF
transcription factors possess an evolutionarily conserved domain,
the DNA-binding High-Mobility-Group (HMG) box: we designed two
guide RNAs (gRNAs) spanning this region within each gene, in order
to create large deletions (Fig 1A). This approach gave us confidence
that such mutations would induce mRNA degradation via non-sense
RNA decay (Brogna & Wen, 2009), or that truncated versions of the
protein would not be able to interact with DNA, resulting in a loss of
function. Using this strategy, we serially mutated the four TCF/LEF
genes and generated a clonal quadruple knockout HEK 293T cell line
(d4TCF) where TCF7, LEF1, TCFL1 and TCFL2 proteins were unde-
tectable via Western blot analysis (Figs 1B and EV1). By exploiting
the same CRISPR/Cas9-mediated strategy, we generated a clone of
HEK 293T cells lacking b-catenin (dBcat). We designed two gRNAs
targeting exon 4 and 12 of CTNNB1, the gene encoding for b-catenin,
thereby creating a 11.5-kb deletion. The absence of b-catenin protein
was confirmed by Western blot (Fig 1B0). In addition, the presence
of the desired genomic deletions at these loci was confirmed by PCR,
using primers flanking the regions near the gRNAs (Fig EV1).
d4TCF or dBcat cells display impaired canonical Wnt signalling
We set out to measure the responsiveness of d4TCF and dBcat cell
lines to Wnt pathway stimulation. We transfected the widely used
Wnt reporter TOP-Flash in parental control HEK 293T, dBcat and
d4TCF cells and measured its transcriptional activity after Wnt
pathway stimulation, achieved via the potent GSK3 inhibitor
CHIRON99021 (hereafter referred to as CHIR) (Naujok et al, 2014).
GSK3 activity leads to b-catenin degradation; CHIR is therefore a
powerful activator of the Wnt pathway (Metcalfe & Bienz, 2011;
Naujok et al, 2014). As expected, no luciferase activity was observed
in both dBcat and the d4TCF cells, while control parental cells
showed a strong, 8,000-fold reporter activation (Fig 1C). Consis-
tently, quantitative RT–PCR (RT–qPCR) revealed that AXIN2, a
prototypical Wnt target gene, was upregulated only in control but
not in dBcat and d4TCF cells (Fig 1D). Other known canonical Wnt
targets behaved in a similar manner (Fig EV2A). In a rescue experi-
ment, transfection of individual TCF-expressing plasmids restores
the ability of d4TCF cells to respond to Wnt3a (Figs 1E and EV2B) or
CHIR stimulation (Figs 1F and EV2C). Interestingly, TCF7L1 failed
to reactivate target genes, consistent with previous reports revealing
an antagonistic relationship between canonical Wnt signalling and
TCF7L1 on gene expression (Yi et al, 2011). These data showed that,
in the absence of b-catenin or TCF/LEF factors, there is no detectable
canonical Wnt signalling transcriptional response, as measured by
TOP-Flash reporter and target gene activation.
d4TCF and dBcat cells are responsive to GSK3 inhibition
We set out to measure the transcriptional effects induced upon
GSK3 inhibition (i.e. CHIR treatment) at a genome-wide level. We
stimulated parental, dBcat and d4TCF cells for 24 h—the time
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frame that showed the strongest activation of AXIN2 (Fig EV2D)—
and performed RNA extraction followed by deep sequencing
(RNA-seq). We compared the transcriptomes of the following six
conditions: unstimulated and CHIR-stimulated parental, dBcat and
d4TCF cells (Fig 2A, Table EV1). The cell lines with different
genotypes formed distinct clusters with and without CHIR treat-
ment, indicating that dBcat and d4TCF cells behave reproducibly,
but differently between them and vis-à-vis the parental cell line
(Fig 2B). Notably, when compared to unstimulated wild-type
parental cells (WT), d4TCF cells displayed significantly broader
gene expression changes (ca. 1,400 deregulated genes) than dBcat
cells (ca. 200 genes; compare Fig 2C and C0). This is consistent
with the mechanism of action of TCF/LEF factors, which bind
Wnt-responsive elements (WREs) even in the absence of active
Wnt signalling (Nusse & Clevers, 2017); this, we believe, might
have led to the large impact on gene expression in “Wnt-OFF”
conditions. Upon GSK3 inhibition, we could detect broad transcrip-
tional changes (upregulated and downregulated genes) both in
dBcat and d4TCF cells (Fig 2D). We validated the expression
changes displaying the highest fold change for each group via RT–
qPCR (Fig 2E). However, as expected, CHIR failed to regulate
canonical Wnt targets in dBcat and d4TCF cells (Figs 1D and 2A,
and EV2A). Importantly, we generated three independent clonal
cell lines for each genotype to exclude the possibility of a bottle-
neck effect (i.e. the generation of clonal cell populations, via
single cells, might affect the overall behaviour of each clone)
(Fig EV3A) and confirmed selected gene expression changes via
RT–qPCR (Fig EV3B). Taken together, our data indicate that GSK3
inhibition leads to a transcriptional response both in the absence
of b-catenin or TCF/LEF proteins.
Uncovering b-catenin-dependent transcriptional changes
Under these experimental conditions, GSK3 inhibition in parental
control cells reproducibly led to the altered expression of 231 genes
(based on adjusted P < 0.05 and absolute log-fold change > 1), 81
of which were upregulated and 150 downregulated in three indepen-
dent experiments (Figs 2A and 3A). GSK3 inhibition, however, has
several effects by stabilizing a considerable proportion of the
proteome—a phenomenon referred to as Wnt/STOP (Acebron et al,
2014; Koch et al, 2015). In order to distinguish those changes that
strictly depend on b-catenin’s activity from the other effects of GSK3
inhibition (e.g. the Wnt/STOP), we aimed at establishing a tran-
scriptional signature of b-catenin. We reasoned that, among the
changes induced by CHIR administration, those that depend on
b-catenin should not vary when b-catenin is absent in dBcat cells.
Of these 231 differentially expressed genes upon CHIR treatment,
166 were not regulated in dBcat cells (Fig 3A, red box), indicating
that these transcriptional changes are a consequence of the nuclear
transcriptional activity of b-catenin. We refer to this group of b-
catenin-dependent changes as high-confidence b-catenin signature.
Of note, this group includes, among the top ten upregulated genes,
known canonical Wnt signalling targets such as DKK1, AXIN2,
NKD1 and SP5 (Fig 2A red boxes, Fig 3A). We interpret this as a
powerful validation of our approach.
d4TCF cells reveal TCF/LEF-independent b-catenin
transcriptional activity
We focused on the high-confidence b-catenin-dependent transcrip-
tional changes and asked whether some of these also occurred in
d4TCF cells (Fig 3A). We identified a set of 27 b-catenin-dependent
genes that are regulated by CHIR in d4TCF (based on adjusted
P < 0.05 and absolute log-fold-change > 1). Therefore, we consider
that ca. 15% of the 166 genes whose expression appears to depend
on the presence of b-catenin do not require the activity of TCF/LEF
transcription factors. With our cut-off values for gene expression,
we could identify upregulated (four genes) and downregulated (23
genes) b-catenin-dependent but TCF/LEF-independent changes.
These transcriptional changes were validated via RT–qPCR in
several independent experiments (Figs 3B and C, and EV3C). In
conclusion, in cells completely devoid of TCF/LEF proteins, b-
catenin is still competent in regulating a subset of its target genes.
This established that b-catenin can, in principle, bypass the activity
of the TCF/LEF transcription factors in HEK 293T human cells.
b-Catenin physically occupies specific genomic regions in the
absence of TCF/LEF transcription factors
If a subset of b-catenin target genes does not require TCF/LEF
factors for their transcriptional regulation, it is plausible that b-
catenin can interact with specific genomic regions independently of
these factors. To test this, we adapted a chromatin immunoprecipi-
tation (ChIP) protocol that enabled us to purify DNA-bound protein
complexes (see Materials and Methods). We then performed ChIP
using an anti-b-catenin antibody, followed by deep sequencing
(ChIP-seq), on both CHIR-stimulated WT and d4TCF cells (Figs 4
and EV4). In WT, parental HEK 293T cells we identified ca. 1,300
high-confidence peaks, that were reproducible in 3 different experi-
ments, even when different b-catenin antibodies were used, but
◀
Figure 1. Quadruple TCF/LEF knockout (K.O.) HEK 293T cells are viable and proliferative but do not respond to Wnt pathway activation.
A Schematic representation of the TCF/LEF protein structure. Below, the guide RNAs (gRNAs) used for each specific gene are annotated. Grey boxes indicate the DNA-
binding HMG box.
B Western blots for detection of TCF7, LEF1, TCF7L1, TCF7L2 and b-catenin (B0) proteins in wild-type (WT) and knockout (K.O.) cells. Uncropped version of the same
Western blots is shown in Fig EV1.
C TCF-reporter TOP-flash assay performed on the indicated cell lines treated with 10 lM CHIR, for 24 h. The control FOP-flash reporter is not activated upon CHIR
administration. The data represent the mean  SEM of averages of nine independent experiments (N = 9). dBcat, b-catenin knockout cells; d4TCF, TCF/LEF
quadruple knockout cells.
D Quantitative RT–PCR analyses of AXIN2 transcripts, performed on the different cell lines treated with 10 lM CHIR or DMSO (control) for 24 h. Error bars show the
standard deviation obtained from three independent experiments.
E, F Transfection of individual TCF-expressing plasmids could restore the ability of d4TCF cells to respond to Wnt3a (E), as measured in a TOP-flash assay, or of CHIR (F),
as measured by AXIN2 mRNA abundance. The data represent the mean  SEM obtained from three independent experiments (N = 3). Samples were compared
using Student’s t-test. Asterisks (*) indicate a P < 0.05.
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absent when ChIP was performed in dBcat cells (Figs 4 and EV4A,
Table EV3). Several of these b-catenin-bound regions were previ-
ously characterized as WREs within the regulatory regions of canon-
ical Wnt target genes, such as AXIN2 and LEF1 (Fig 4A). b-Catenin
did not display any enrichment at known WREs in d4TCF cells
(Fig 4A), confirming the requirement of TCF/LEF proteins for the
correct positioning of b-catenin at these loci. Interestingly, some loci
retained b-catenin enrichment in d4TCF cells (Fig 4B) even though
genome-wide occupancy at TCF-bound regions was lost (Fig 4C)
indicating that in the absence of TCF/LEF, b-catenin may associate
with other transcription factors. While the number of TCF-indepen-
dent b-catenin peaks appeared to be variable in different experi-
ments, likely due to different pull-down efficiencies or perturbation
of culture conditions (Fig EV4B, Table EV3), we identified a small
subset of ca. 30 highly reproducible TCF-independent binding
regions (Fig EV4C). In our analyses, we could not determine a direct
relationship between TCF/LEF-independent peak-associated (ChIP-
seq) and CHIR-regulated genes (RNA-seq). However, transcription
factors binding does not necessarily occur at the cognate promoter
of the genes, but could take place in distant enhancer regions
(Dickel et al, 2013). We therefore defined a gene as “associated”
when a ChIP peak is found within 50 kb from its transcriptional
start site (TSS). This is the average distance of genes from CTCF
peaks (~48 kb) and interacting promoters (Kim et al, 2007). The
intersection between RNA-seq and ChIP-seq data showed that
upregulated genes in WT were significantly more likely to be associ-
ated with b-catenin peaks in WT than expected by chance (3.987-
fold increase) while genes upregulated in d4TCF cells were not
(Fig EV4D). On the contrary, the fraction of downregulated genes
in d4TCF was more likely to be associated with b-catenin binding
upon CHIR stimulation (9.136-fold in d4TCF, 9.489-fold in WT,
Fig EV4E). Importantly, while in WT cells b-catenin-dependent
(2.083-fold) and TCF-dependent (2.388-fold) genes were more likely
to have peaks in their proximity, in d4TCF cells, b-catenin-depen-
dent but TCF-independent genes became the group with highest
association with ChIP-seq peaks (52.236-fold increase, Fig EV4F).
This suggests a strict requirement for TCF/LEF and b-catenin in WT
cells, whereas b-catenin is relocated to TCF-independent target
genes in d4TCF cells. Together, these findings indicate that in the
absence of TCF/LEF, CHIR-stabilized b-catenin could embark on an
alternate modus operandi, likely in association with other transcrip-
tion factors. Indeed, whereas b-catenin-bound regions in wild
type were highly enriched for the TCF consensus binding motif
(Fig 4D), d4TCF cells only showed significant motif enrichment
(P < 1 × 1010, hypergeometric test) for Forkhead box (FOX) family
of transcription factors (Fig 4E). Furthermore, all b-catenin peaks in
d4TCF cells containing the TCF binding sequence also contained a
FOX motif (Fig 4F), suggesting that b-catenin is recruited by FOX
proteins in the absence of TCF/LEF.
b-Catenin activity in the absence of TCF/LEF: the b-catenin-
GHOST response
Our RNA-seq and ChIP-seq results raised the possibility of a new b-
catenin-dependent transcriptional program in the absence of TCF/
LEF. We tested the existence of this by analysing the CHIR-depen-
dent transcriptional response of d4TCF cells. CHIR-treated d4TCF
cells displayed statistical changes in the transcription of 196 genes
(N = 3, P < 0.05) (Fig 5A, Table EV2), and an unexpectedly large
fraction of these changes (134, Fig 5A) occurred in d4TCF but not in
control parental HEK 293T cells. Note that all changes were, by defi-
nition, independent of TCF/LEF proteins. Two-third of these gene
expression changes (134) appeared to depend on b-catenin (Fig 5A),
in that they did not occur in dBcat cells upon CHIR stimulation.
Importantly, this list included the 27 b-catenin-dependent TCF/LEF-
independent targets we previously identified (Fig 5A). The other 107
differentially expressed genes (Fig 5A, blue box) can therefore be
considered as b-catenin targets, but their regulation occur only in the
absence of TCF/LEF. It remained, however, possible that this group
of 107 genes were not regulated by CHIR in dBcat because
this mutant cell clone still possesses the TCF/LEF factors. To exclude
this possibility and obtain conclusive evidence that b-catenin is
required for their regulation specifically in a TCF/LEF quadruple
knockout context, we introduced a loss-of-function mutation in
CTNNB1 in d4TCF cells, thereby generating a quintuple knockout
cell line devoid of TCF/LEF and b-catenin proteins (we refer to this
cell line as pentaKO). We performed RNA-seq of pentaKO cells
(N = 3) and confirmed that at least 90 of the 107 b-catenin-depen-
dent genes were either not upregulated in pentaKO (n = 74) or their
transcript was undetectable (n = 16) indicating absence of transcrip-
tional regulation. We refer to this set of 90 genes as the b-catenin-
GHOST response (genes hidden outside the standard targets). We
validated a subset of b-catenin-GHOST targets via RT–qPCR, show-
ing that they respond to CHIR treatment in d4TCF cells but not in
pentaKO cells, thereby conclusively confirming their dependence on
b-catenin (Fig 5B, Table EV2).
The b-catenin-GHOST response was only detected upon the
non-physiological removal of all TCF/LEF encoding genes. There-
fore, we set out to test whether the use of physiological inhibitors
of the TCF-b-catenin interaction could drive the expression of
◀
Figure 2. RNA-seq analyses of CHIR-treated HEK 293T cells in the absence of TCF/LEF or b-catenin.
A Heat map showing the upregulated genes in wild-type (WT) parental HEK 293T cells upon CHIR treatment, ranked based on the log2 fold change. Increased and
decreased transcription is depicted in red and blue, respectively. Gene names are indicated along the y-axis. Canonical Wnt targets are among the most upregulated
genes in WT cells (red boxes). The genotypes of the cell clones used are indicated on the bottom of the heat map. Triplicates of each cell line are included.
B Hierarchical clustering of differentially expressed genes with at least a twofold change in any comparison. Dendrogram clustering indicates the relationships between
the different experimental conditions.
C Volcano plot displays differentially regulated genes in d4TCF (C) and dBcat (C0) compared to WT parental cells. Red dots indicate significantly regulated genes based
on adjusted P-value and log-fold change (logFC).
D Smear plots for every cell line indicating the behaviour of every gene after CHIR treatment. Differential gene expression is indicated by the log2 fold change (logFC),
and the average logCPM (logarithm of counts per million reads) was used to estimate the accuracy of the expression level.
E RT–qPCR-based validation of three differentially expressed genes, upon CHIR stimulation in WT, dBcat or d4TCF cell lines. The data represent the mean  SEM of
averages of three independent experiments (N = 3). Samples were compared using Student’s t-test. Asterisks (*) indicate a P < 0.05, and (**) a P < 0.01.
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Figure 3. Differential gene expression analysis reveals b-catenin-dependent but TCF/LEF-independent transcriptional changes.
A 231 genes were regulated in wild-type (WT) parental HEK 293T cells upon CHIR treatment (a minimum of twofold change). 166/231 of these transcriptional changes
do not occur in dBcat cells and are therefore considered as b-catenin-dependent (red box). 27/166 b-catenin targets are also regulated in d4TCF cells indicating
that they are TCF-independent.
B, C RT–qPCR-based validation of selected TCF-independent b-catenin-dependent target genes (B) upregulated or (C) downregulated in d4TCF cells (TCF-independent)
treated with 10 lM CHIR or DMSO for 24 h. Data represent the mean  SEM of averages of three independent experiments (N = 3). Samples were compared using
Student’s t-test. Asterisks (*) indicate a P < 0.05.
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b-catenin-GHOST targets. We reasoned that blocking the TCF-b-
catenin interaction in WT cells would mimic the TCF/LEF quadru-
ple KO condition of d4TCF cells. To achieve this, we overex-
pressed the inhibitor of b-catenin and TCF (ICAT), a 9-kDa
polypeptide that impairs canonical Wnt signalling by competing
with TCF/LEF for their interaction to b-catenin (Tago et al, 2000).
ICAT overexpression inhibited CHIR-mediated AXIN2 upregulation
(Fig EV5A), confirming its ability to block the TCF-b-catenin inter-
action in HEK 293T cells. Importantly, ICAT overexpression
allowed the CHIR-dependent b-catenin-GHOST response: the same
set of b-catenin-GHOST targets that could only be upregulated by
CHIR in d4TCF cells, was also induced by ICAT overexpression
(Fig 5B).
b-Catenin interplay with FOXO transcription factors
We observed a statistical in silico enrichment of FOX motifs










































































































































































Figure 4. b-Catenin genome-wide occupancy in the presence or in the absence of TCF/LEF transcription factors.
A–C (A, C) Genome browser-based schematic representation of b-catenin peaks in control wild-type (WT), d4TCF or dBcat cells. (A, B) b-Catenin occupancy on
regulatory regions of the prototypical Wnt target genes, AXIN2 and LEF1 (A), and at the promoter regions of HOXC4 and ZNF503 (B). (C) b-Catenin ChIP-seq
enrichment over ENCODE TCF7L2 (also known as TCF4) ChIP peaks in HEK 293T cells. The data represent the mean  95% C.I. obtained from three independent
experiments (N = 3).
D, E Motif analysis of b-catenin peaks in WT (D) and d4TCF cells (E).
F Fraction of peaks containing FOX (“TGAGWARAMWCC”), TCF (“CCTTTGAAST”) or both motifs, allowing maximum 1 mismatch.
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suggesting that at least part of the b-catenin-GHOST response might
be co-regulated by FOXO transcription factors. Consistent with this
hypothesis, among the top 30 regulated genes within the b-catenin-
GHOST signature, we also found known FOXO targets, such as
BCL6, BNIP3 and the growth arrest and DNA damage gene GADD45
(van der Vos & Coffer, 2011). Of note, FOXO transcription factors
have been identified as b-catenin cofactors in different cellular
contexts (Essers, 2005; Hoogeboom et al, 2008). GADD45, in partic-
ular, has been reported to be a target of FOXO3 and a FOXO4 (van
der Vos & Coffer, 2011). We set out to overexpress FOXO3 and
FOXO4 in control parental and d4TCF cells, simultaneously trigger
b-catenin stabilization with CHIR and monitor the expression of
GADD45. In WT untreated cells, FOXO4, but not FOXO3, leads to
GADD45 induction (Fig 5C). In d4TCF cells, while FOXO4 alone
could mildly induce GADD45, the highest induction was obtained
when FOXO4 was expressed in CHIR-treated cells (Fig 5D). The
FOXO4-dependent induction of GADD45 was dependent on b-
catenin, as it did not occur in dBcat cells (Fig 5D). As previously
shown (Essers, 2005; Hoogeboom et al, 2008), FOXO4 physically
interacts with activated b-catenin, in a dose-dependent manner, also
in HEK 293T (Fig 5E). Finally, the addition of FOXO4-specific siRNA
—but not control scrambled siRNA—blocked the CHIR-mediated
induction of GADD45 expression (Figs 5F and EV5B and C). Taken
together, these results support the notion that, in the absence of
TCF/LEF, b-catenin can co-operate with other transcription factors,
and FOXO4 plays a role in the transcription of at least a subset of
target genes.
Discussion
Here, we generated a series of HEK 293T cell clones lacking all
members of the TCF/LEF transcription factor family. This new tool
allowed us to probe for the existence of TCF/LEF-independent
b-catenin activity (Fig 1). We established a high-confidence list of
b-catenin-dependent targets, which comprise exclusively those
genes whose expression does not change in the absence of b-catenin
when HEK 293T cells are stimulated with CHIR. A significant 15%
of this set was regulated by b-catenin irrespectively of the presence
or absence of TCF/LEF transcription factors.
Our data convincingly support the paradigmatic view that has
been established in the past years of how nuclear Wnt signalling is
executed: the vast majority of the b-catenin-dependent transcrip-
tional effects, including the well-established targets such as AXIN2,
SP5 and DKK1, require the TCF/LEF transcription factors (Figs 2
and 3). Consistently, the genome-wide physical association of
b-catenin with DNA is also largely perturbed when TCF/LEF are
mutated (Fig 4).
On the other hand, our unbiased approach allowed us to identify
a subset of b-catenin targets whose regulation does not require the
TCF/LEF proteins. This seems to be in line with previous reports,
indicating that b-catenin can bind to alternative non-TCF transcrip-
tion factors (Essers, 2005; Vadlamudi, 2005; Kaidi et al, 2007; Kim
et al, 2008; Kormish et al, 2009). Our study, however, did not allow
us to identify all the transcriptional regulators that, in our experi-
mental system, form a complex with b-catenin to regulate TCF/LEF-
independent targets. An interesting question for future studies will
be to assess whether the TCF-independent b-catenin targets all rely
on the activity of a single alternative transcription factor (e.g.
FOXO4), or whether different targets are regulated by distinct b-
catenin partners. On the other hand, we could identify at least one
target gene, GADD45, whose expression is driven by the simultane-
ous action of b-catenin and the Forkhead transcriptional regulator
FOXO4 (Fig 5E). This provides the proof-of-principle that alterna-
tive mechanisms of action other than the canonical TCF/
b-catenin-mediated transduction exist. However, we cannot exclude
the possibility that TCF-independent b-catenin targets reflect an
indirect effect caused by cytoplasmic functions of b-catenin as part
of the destruction complex in the absence of Wnt signals (Nusse &
Clevers, 2017). The destruction complex, via the promiscuous activ-
ity of GSK3, acts on a plethora of proteins (Taelman et al, 2010),
and it is possible that the genetic removal of b-catenin may affect
the regulation of several genes as a consequence of its impaired
activity.
Overall, our observation broadens the spectrum of potential Wnt
targets in different tissues: in fact, it paves the way for
▸
Figure 5. b-Catenin drives a GHOST response in the absence of TCF/LEF transcription factors.
A Differential gene expression analysis shows a set of 196 genes being regulated by CHIR in d4TCF cells; several of these changes only appear when TCF/LEF proteins
are not present (dark green set). Of the 134 genes that are not regulated by CHIR in dBcat cells (putative b-catenin-dependent genes), 107 require the removal of
TCF/LEF factors, in that their regulation only occurs in d4TCF cells. The other 27/134 b-catenin-dependent transcriptional changes match the TCF/LEF-independent
target genes previously described in Fig 3A. Their regulation occurs both in the presence and in the absence of TCF/LEF factors. 90/107 of the putative b-catenin-
dependent genes, stop being regulated by CHIR in pentaKO cells (b-catenin-GHOST, blue box).
B RT–qPCR validation of the b-catenin-GHOST response. A selection of 7 genes (colour coded) that are activated upon CHIR treatment in d4TCF, or in wild type (WT) in
combination with ICAT overexpression, but not in pentaKO cells—indicating that their regulation is dependent on b-catenin but can only occur in the absence of
TCF/LEF-b-catenin interaction. The genotype and the treatment for each condition are indicated in the x-axis. Error bars show the standard deviation obtained from
three independent experiments.
C FOXO4 but not FOXO3 overexpression upregulates the b-catenin-GHOST target GADD45 both in CHIR-treated WT (black bars) and in d4TCF (grey bars) cells. Samples
were compared using Student’s t-test. Asterisks (*) indicate a P < 0.05.
D FOXO4 overexpression induced GADD45 transcription in WT (black bars) but not in dBcat (grey bars) cells. Samples were compared using Student’s t-test. Asterisks (*)
indicate a P < 0.05.
E Endogenous FOXO4, when immunoprecipitated (IP) pulls down b-catenin. Overexpressed FOXO4 increases the amount of b-catenin detected in the
immunoprecipitated, indicating physical association.
F GADD45 is upregulated by CHIR in d4TCF cell; this positive transcriptional regulation is blocked by FOXO4-specific siRNA but not control scrambled siRNA. All
experiments were done at least three times (N = 3). Samples were compared using Student’s t-test. Asterisks (**) indicate a P < 0.02; ns, non-statistically significant
change was observed.
Source data are available online for this figure.
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understanding how b-catenin stabilization could regulate different
sets of targets within the same cells or in different tissues, namely
by complexing with different partners capable of recognizing a wide
range of DNA motifs present in gene regulatory regions.
Interestingly, among the TCF-independent b-catenin target loci
(i.e. ChIP-seq peaks), we could identify peaks whose size (i.e. the
fold enrichment) was unchanged upon loss of TCF/LEF (Fig 4C):
we interpret this as an entirely TCF-independent binding event. On
the other hand, other peaks were decreased in size, but still present,
such as at the ZNF503 locus (Fig 4C). It is possible that this second
binding behaviour reflects the fact that b-catenin relies on the pres-
ence of TCF/LEF in co-operation with other transcription factors,
such as FOXO4. This view is supported by the observation that
ZNF503 and its antisense transcript require TCF/LEF for their tran-
scriptional regulation (Table EV1). Importantly, also, all b-catenin
peaks in d4TCF cells containing a TCF motif also contained a FOX
binding motif (Fig 4F). In this scenario, the removal of TCF/LEF
could attenuate, but not fully abolish, b-catenin occupancy at this
region, and transcriptional regulation of the affected gene. Collec-
tively, these data constitute powerful evidence that the association
of b-catenin to a subset of genomic regions cannot be entirely
explained by its association with TCF/LEF proteins and must
require additional coupling with alternative DNA-binding partners.
Possibly the most interesting discovery we made was the obser-
vation that in a cellular context devoid of TCF/LEF proteins, b-
catenin acquires an entirely new set of transcriptional targets
(Fig 5). We provide evidence for this at the RNA level, by showing
that a new group of genes is transcriptionally regulated by b-
catenin, upon CHIR treatment, only when TCF/LEF genes are
mutated. These b-catenin targets are not only TCF-independent, but
they require the inhibition of the TCF-b-catenin interaction, or the
loss of TCF/LEF expression. It is possible that, in normal conditions,
the b-catenin nuclear protein is present in limiting amount, and
DNA-b-catenin interaction is predominantly mediated by TCF/LEF,
preventing the co-operation with other potential protein partners.
The removal of TCF/LEF, however, might release b-catenin to bind
to different interactors. Of course, we are aware that the loss of
function of all TCF/LEF encoding genes might lead to an artefactual
scenario that does not necessarily parallel a physiologically relevant
condition. Additional studies are required to address whether the b-
catenin-GHOST response can take place during organismic develop-
ment, homeostasis or, perhaps in disease condition, upon physiolog-
ical Wnt stimulation. Interestingly enough, the expression of ICAT,
a small protein physiologically capable of impairing the b-catenin–
TCF interaction in vivo, can mimic the genetic removal of TCF/LEF
genes (Fig 5B). It appears therefore that, when b-catenin is “liber-
ated” by the affinity with TCF/LEF proteins, it becomes free to regu-
late new sets of targets by forming new partnerships. In this light,
we speculate that the many physiologically occurring peptides, like
ICAT itself (Hossain et al, 2008), or the dominant negative isoforms
of LEF-1 and TCF7 (Yokoyama et al, 2010; Sprowl-Tanio et al,
2016), might function in vivo as molecular switches capable of
unleashing b-catenin from its canonical role, and permitting the acti-
vation of the b-catenin-GHOST response. It is also plausible that the
b-catenin-GHOST response is a variable entity that strictly depends
on the tissue context: different sets of transcription factors might be
present in different cell types. b-Catenin has a recognized role as a
scaffold protein (Valenta et al, 2012): in canonical Wnt signalling,
b-catenin can tether a cohort of transcriptional regulators to WREs
and functionally couple them with the Pol II complex. Perhaps b-
catenin can act as a promiscuous transcriptional effector, capable of
connecting the function of other transcription factors with the
general transcriptional machinery.
Finally, our work brings forward the tantalizing hypothesis that
other developmental signalling pathways might possess a hidden
response when the key transcription factors are limiting, not
expressed or prevented from interacting with their upstream path-
way component (e.g. GLI proteins in SHH signalling; Rimkus et al,
2016). Uncovering potential further GHOST responses might lead to
a new understanding of how downstream effectors of signalling
cascades modulate different tissue-specific responses.
Materials and Methods
Cell culture
Human embryonic kidney (HEK) 293T cells were cultured in media
consisting of DMEM, high glucose (41966-029 Gibco) supplemented
with 10% foetal bovine serum (Gibco), 1× penicillin–streptomycin
according to the manufacturer’s recommendation.
CRISPR guide RNAs
Guide RNAs (sgRNAs) were designed with the online tool: Opti-
mized CRISPR design (http://crispr.mit.edu/) and were cloned into
the pSpCas9(BB)-2A-Puro (PX459) (Addgene plasmid ID: 48139) as
previously described in Ran et al (2013). All sgRNAs used are listed
in Table EV4.
Generation of K.O. cell lines using CRISPR/Cas9
Two single-guide RNAs, targeting simultaneously either two exons
or an exon and an intron of each TCF/LEF (see table), respectively,
were cloned separately into pSpCas9(BB)-2A-Puro (PX459) in order
to sequentially ablate all full-length TCF/LEF isoforms. The
constructs were co-transfected transiently in HEK 293T cells using
Fugene according to the manufacturer’s recommendation, and 24 h
after transfection, puromycin selection was applied for an additional
48 h. Cells were then split and seeded at clonal density. Clones from
single cells were manually picked and analysed by Western blot for
the expression of TCFs. The same approach was used also for the
generation of the beta-catenin K.O. Table shows the gRNA sequence
and the corresponding target region.
Western blot analyses
Cell lysates were mixed with LDS sample buffer supplemented with
sample reducing agent (invitrogen) and boiled for 5 min at 95°C. 10–
15 mg of protein/lane was run through 10% Bis–Tris gels (120 V,
90 min). Proteins were transferred onto polyvinylidene fluoride
(PVDF) membranes with a Bio-Rad Mini Trans-Blot System (35 V,
3 h). Membranes were blocked with 5% milk/PBS-T (phosphate-
buffered saline supplemented with tween 20) for 45 min in room
temperature (RT) and incubated with primary antibodies diluted in
5% bovine serum albumin/PBS-T overnight at 4°C. Blots were
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washed with PBS-T (four times, 15 min/wash) and incubated with
horseradish peroxidase (HRP)-conjugated secondary antibodies
(1 h, RT). After four washes with 15 min in PBS-T, blots were
incubated in WesternBright Quantum (Advansta) and imaged by
using a Fusion SL imaging System (Vilmer). The following primary
antibodies were used for Western blot: mouse anti-a-tubulin (T6074,
Sigma-Aldrich), rabbit anti-TCF7 (C63D9, Cell Signaling), rabbit
anti-LEF1 (C12A5, Cell Signaling), rabbit anti-TCF7L1 (D15G11, Cell
Signaling), rabbit anti-TCF7L2 (C48H11, Cell Signaling), rabbit anti-
b-catenin (SantaCruz sc-7199). Horseradish peroxidase-conjugated
secondary anti-mouse and anti-rabbit antibodies for Western blotting
were purchased from Jackson.
Plasmid list
The following plasmids were obtained from Addgene: pSpCas9(BB)-
2A-Puro (PX459), pcDNA3flagFKHRL1 (FOXO3) (#10709), pcDNA-
HA-TCF1 (TCF7) (#40620), pcDNA-myc-TCF4 (TCF7L2) (#16512),
pc-DNA3hE47 (TCF7L1) (#16059). The pCMV-ICAT was a kind gift
from Prof. Christian Mosimann. The FOXO4 expressing plasmid was
kindly provided by Prof. P.J. Coffer. The LEF1 expressing plasmid
was kindly provided by Prof. Marc de la Roche.
qRT–PCR
Total RNA (1 lg) isolated using the PureLink RNA Mini Kit
(Thermo Fisher Scientific) was used to generate cDNA with Tran-
scription High Fidelity cDNA Synthesis Kit (Roche) and then
treated with DNA-free Kit (Thermo Fisher Scientific). SYBR Green
SuperMix (Bio-Rad) was used for qPCRs using 3 ll of diluted
cDNA (1 lg RNA equivalent in 100 ll). GAPDH was used as the
reference gene. QuantStudio 3 (Thermo Fisher Scientific) instru-
ment and software were used to determine relative gene expres-
sion levels using the delta–delta Ct method. Primer sequences
were designed using Roche’s online primer design software
(https://lifescience.roche.com/en_ch/brands/universal-probe-library.
html) or were obtained from prior publications and are listed in
Table EV5. Statistical analyses (two-tailed Student’s t-test) was
performed in Microsoft Excel considering both independent experi-
ments and technical repetitions. Each experiment was performed at
least three times.
TCF/LEF reporter assays
HEK 293T cells were co-transfected with the constructs 8XTOPFlash
or 8XFOPFlash, driving firefly luciferase production, and pRL-CMV,
driving constitutive expression of Renilla luciferase for normalization
(Promega). For experiments performed with 10 lM CHIR99021,
293T cells were resuspended directly into the appropriate media.
Cells were washed twice with PBS 48 h following transfection and
lysed with 1× passive lysis buffer (Promega). The firefly and luci-
ferase activities were measured using a 96-well-based luminometer
as per the manufacturer’s instructions (Promega Dual-Light System).
siRNA transfection
For the FOXO4 siRNA transfections the Dharmacon RNAi, Gene
expression & Gene Editing reagents were used. HEK 293T cells were
plated in 24-well plate the day before transfection (60% confluency)
in antibiotic-free complete medium. Cells were incubated overnight
at 37°C with 5% CO2. Negative control (ON-TARGET plus non-
targeting pool D-001810-10-05) and test siRNAs (ON-TARGET plus
SMART pool FOXO4 siRNA L-003016-00-0005) were used in 5 nM
final concentration. The transfections were performed according to
the DharmaFECT1 transfection reagent protocol. Transfection
medium was replaced with complete new medium, supplemented
with 10 lΜ final concentration CHIR, after 24 h to reduce cytotoxic-
ity and to stimulate the Wnt pathway. 24 h later, cells were
harvested and analysed with qRT–PCR.
Chromatin immunoprecipitation
Cells were treated with 10 lM CHIR or 10 lM DMSO for 24 h prior
to cross-link. Ca. 50 × 106 HEK cells per samples were cross-linked
in 20 ml PBS for 40 min with the addition of 1.5 mM ethylene
glycol-bis(succinimidyl succinate) (Thermo Scientific, Waltham,
MA, USA), for protein–protein cross-linking (Schuijers et al, 2014),
and 1% formaldehyde for the last 20 min of incubation, to preserve
DNA–protein interactions. The reaction was blocked with glycine
and the cells were subsequently lysed in 1 ml HEPES buffer (0.3%
SDS, 1% Triton X-100, 0.15 M NaCl, 1 mM EDTA, 0.5 mM EGTA,
20 mM HEPES). Chromatin was sheared using Covaris S2 (Covaris,
Woburn, MA, USA) for 8 min with the following set up: duty cycle:
max, intensity: max, cycles/burst: max, mode: Power Tracking.
The sonicated chromatin was diluted to 0.15% SDS and incubated
overnight at 4°C with 10 lg of anti-b-catenin (SantaCruz sc-7199;
Cell Signaling) and 50 ll of protein A/G magnetic beads (Upstate).
The beads were washed at 4°C with wash buffer 1 (0.1% SDS,
0.1% deoxycholate, 1% Triton X-100, 0.15 M NaCl, 1 mM EDTA,
0.5 mM EGTA, 20 mM HEPES), wash buffer 2 (0.1% SDS, 0.1%
sodium deoxycholate, 1% Triton X-100, 0.5 M NaCl, 1 mM EDTA,
0.5 mM EGTA, 20 mM HEPES), wash buffer 3 (0.25 M LiCl,
0.5% sodium deoxycholate, 0.5% NP-40, 1 mM EDTA, 0.5 mM
EGTA, 20 mM HEPES) and finally twice with Tris EDTA buffer.
The chromatin was eluted with 1% SDS, 0.1 M NaHCO3, de-
cross-linked by incubation at 65°C for 5 h with 200 mM NaCl,
extracted with phenol–chloroform and ethanol-precipitated. The
immunoprecipitated DNA was used as input material for DNA deep
sequencing.
ChIP-seq data analysis: ChIP-seq reads were mapped using the
Bowtie2 (http://bowtie-bio.sourceforge.net/bowtie2/index.shtml)
onto the UCSC hg19 reference human genome. Peaks were called
against Input controls using MACS2 (https://github.com/taoliu/
MACS/) (Zhang et al, 2008) (using flag –nomodel) and peaks over-
lapping known problematic ChIP regions from ENCODE (wgEnco
deHg19ConsensusSignalArtifactRegions.bed) were excluded. Next,
peaks identified in the majority of replicates (within 500 bp from
peak centre) were kept (Yang et al, 2014). Motif enrichment analy-
sis of peaks was performed using Homer2 (PMID: 20513432). Deep-
Tools (Ramı́rez et al, 2016) was used to calculate genome-wide
coverage against Input controls (bamCompare –e 200 –ignoreDupli-
cates) and plot enrichment over features (plotHeatmap). Public
ENCODE ChIP peaks used as features were obtained for
ENCFF002CRP (TCF7L2, also known as TCF4), and peaks within
500 bp for each file were merged. For merged peaks, randomly
sampled regions were obtained and used to normalize for overall
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signal levels between experiments. The data have been deposited at
the ArrayExpress database, accession number E-MTAB-7028.
Transcriptome analyses
RNA from HEK 293T cells was extracted using TRIzol reagent
(Ambion); libraries were prepared with TruSeq RNA stranded
library preparation and sequenced on NextSeq 500, 1 × 75 bp.
Reads in FASTQ format from the 18 samples (six conditions with
three biological replicates each) were quantified at the gene level
with featureCounts (Liao et al, 2014) using the built-in human
EntrezGene annotation. The count table was delivered to edgeR
(Robinson et al, 2010) for the differential expression analysis using
the GLM functionality (McCarthy et al, 2012) (R version 3.3.0,
edgeR version 3.14.0). To determine differential expression, pair-
wise contrasts of interest were designed, a likelihood ratio test was
calculated, and a Benjamini–Hochberg multiple testing correction
(estimated FDR of 5%) with minimum absolute fold change of 1.5
was applied. Heat maps were generated using the pheatmap pack-
age. The data have been deposited at the ArrayExpress database,
accession number E-MTAB-7029.
Expanded View for this article is available online.
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